COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1621: Articles 16201-16210  | Next

Reduced Pediatric Urgent Asthma Utilization and Exacerbations During the COVID-19 Pandemic
Hurst, J. H., Zhao, C., Fitzpatrick, N. S., Goldstein, B. A., Lang, J. E.
10.1101/2021.04.28.21256263 — Posted: 2021-05-01
Changes in English NHS outpatient activity during the early Covid-19 period
Morris, J. S., Georghiou, T., Appleby, J.
10.1101/2021.04.28.21256176 — Posted: 2021-05-01
Sustained seroprevalence of anti SARS-CoV-2 total immunoglobulins in asymptomatic blood donors
Martin, M. C., Gonzalez, M. I., Holgado, N., Jimenez, A., Ortega, N., Page, I., Parrado, A., Perez, M., Blanco-Peris, L.
10.1101/2021.04.28.21256242 — Posted: 2021-05-01
Transmission dynamics of SARS-CoV-2 in the hospital setting
Mo, Y., Eyre, D. W., Lumley, S., Walker, T., Shaw, R., O'Donnell, D., Butcher, L., Jeffery, K., Donnelly, C. A., Oxford COVID infection review team, , Cooper, B. S.
10.1101/2021.04.28.21256245 — Posted: 2021-05-01
Pre-pandemic SARS-CoV-2 potential natural immunity among population of the Democratic Republic of Congo
SOURIS, M., TSHILOLO, L., PARZY, D., KAMGAING, R., MBONGI, D., PHOBA, B., TSHILOLO, M.-A., MBUNGU, R., MORAND, P., GONZALEZ, J.-P.
10.1101/2021.04.28.21256243 — Posted: 2021-05-01
Elevated blood glucose levels as a primary risk factor for the severity of COVID-19
Logette, E., Lorin, C., Favreau, C. P. H., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M. L., Delattre, E., Fonta, P.-A., Krepl, J., Schmidt, S., Keller, D., Kerrien, S., Scantamburlo, E., Kaufmann, A.-K., Markram, H.
10.1101/2021.04.29.21256294 — Posted: 2021-05-01
Evolutionary insights into a non-coding deletion of SARS-CoV-2 B.1.1.7
Yang, J., Zhang, G., Yu, D., Cao, R., Wu, X., Ling, Y., Pan, Y.-H., Yi, C., Sun, X., Sun, B., Zhang, Y., Zhao, G.-P., Li, Y., Li, H.
10.1101/2021.04.30.442029 — Posted: 2021-05-01
Decitabine Reactivation of FoxM1-Dependent Endothelial Regeneration and Vascular Repair for Potential Treatment of Elderly ARDS and COVID-19 Patients
Huang, X., Zhang, X., Machireddy, N., Mutlu, G., Fang, Y., Wu, D., Zhao, Y.-Y.
10.1101/2021.04.29.442061 — Posted: 2021-04-30
Influenza viral particles harboring the SARS-CoV-2 spike RBD as a combination respiratory disease vaccine
Chaparian, R. R., Harding, A. T., Riebe, K., Karlsson, A., Sempowski, G. D., Heaton, N. S., Heaton, B. E.
10.1101/2021.04.30.441968 — Posted: 2021-04-30
Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine
Sapkal, G., Yadav, P., Ella, R., Abraham, P., Patil, D., Gupta, N., Panda, S., V, K. M., Bhargava, B.
10.1101/2021.04.30.441559 — Posted: 2021-04-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).